Amoxapine (Compound)

Synonyms:amoxapine, 14028-44-5, Asendin, Demolox, Moxadil, Amoxan, Desmethylloxapin, Amoxapina, Amoxapinum, Amoxepine, CL-67772, Dibenz[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-, CL 67772, 2-Chloro-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepine, 8-chloro-6-piperazin-1-ylbenzo[b][1,4]benzoxazepine, CL-67,772, CL 67,772, Asendis, NSC-759559, DIBENZ(b,f)(1,4)OXAZEPINE, 2-CHLORO-11-(1-PIPERAZINYL)-, CHEMBL1113, 2-Chloro-11-(1-piperazinyl)dibenz[b,f][1,4]oxazepine, MLS000069371, 2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine, CHEBI:2675, R63VQ857OT, DTXSID7022598, 2-chloro-11-piperazin-1-yldibenzo[b,f][1,4]oxazepine, NCGC00015004-09, Ascendin, SMR000058416, CAS-14028-44-5, Amoxapinum [INN-Latin], Amoxapina [INN-Spanish], DTXCID102598, (E)-2-chloro-11-(piperazin-1-yl)dibenzo[b,f][1,4]oxazepine, Asendin (TN), SR-01000003001, EINECS 237-867-1, MFCD00069210, amoxipine, BRN 0832057, UNII-R63VQ857OT, 2-Chlor-11-(1-piperazinyl)dibenz(b,f)(1,4)oxazepin, Amoxapine-[d8], Prestwick_503, Amoxapine [USAN:USP:INN:BAN:JAN], KS-1197, Opera_ID_33, Spectrum_000446, CPD000058416, AMOXAPINE [INN], AMOXAPINE [JAN], AMOXAPINE [MI], Lopac-A-129, AMOXAPINE [USAN], Prestwick0_000102, Prestwick1_000102, Prestwick2_000102, Prestwick3_000102, Spectrum2_001245, Spectrum3_001067, Spectrum4_001218, Spectrum5_001284, AMOXAPINE [VANDF], A-129, AMOXAPINE [MART.], AMOXAPINE [USP-RS], AMOXAPINE [WHO-DD], Lopac0_000116, REGID_for_CID_2170, SCHEMBL33950, BSPBio_000084, BSPBio_002654, GTPL201, KBioGR_001656, KBioSS_000926, MALEICACIDMONOSODIUMSALT, DivK1c_000236, SPECTRUM2300161, SPBio_001150, SPBio_002023, Amoxapine (JP17/USP/INN), BPBio1_000094, AMOXAPINE [ORANGE BOOK], 2-Chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepine, 8-chloro-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine, AMOXAPINE [USP IMPURITY], BDBM22870, HMS500L18, KBio1_000236, KBio2_000926, KBio2_003494, KBio2_006062, KBio3_001874, AMOXAPINE [USP MONOGRAPH], NINDS_000236, HMS1568E06, HMS2089G10, HMS2093N08, HMS2095E06, HMS2231E13, HMS3259G08, HMS3260G14, HMS3370P03, HMS3712E06, Pharmakon1600-02300161, HY-B0991, Tox21_110064, Tox21_302352, Tox21_500116, CCG-39135, NSC759559, PDSP1_001609, PDSP2_001593, s4218, AKOS015895092, Tox21_110064_1, AC-5495, CS-4485, DB00543, LP00116, NC00546, NSC 759559, SDCCGSBI-0050104.P004, IDI1_000236, NCGC00015004-01, NCGC00015004-02, NCGC00015004-03, NCGC00015004-04, NCGC00015004-05, NCGC00015004-06, NCGC00015004-07, NCGC00015004-08, NCGC00015004-10, NCGC00015004-11, NCGC00015004-13, NCGC00015004-16, NCGC00015004-22, NCGC00023887-03, NCGC00023887-04, NCGC00023887-05, NCGC00023887-06, NCGC00255124-01, NCGC00260801-01, 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3(8),4,6,9,12,14-heptaene, BA164170, SBI-0050104.P003, EU-0100116, FT-0659871, FT-0662122, A16406, D00228, EN300-123014, Q58356, T70258, AB00052421-13, AB00052421_14, AB00052421_15, A807639, L001293, J-007373, SR-01000003001-2, SR-01000003001-4, SR-01000003001-6, 8-chloro-6-piperazin-1-ylbenzo[b][1,5]benzoxazepine, BRD-K02265150-001-05-9, BRD-K02265150-001-15-8, 2-Chloro-11-(1-piperazinyl)dibenz[b,f]-1,4-oxazepine, 2-Chloro-11-(1-piperazinyl)dibenzo[b,f]-1,4-oxazepine, 2-Chloro-11-piperazin-1-yl-dibenzo[b,f][1,4]oxazepine, 8-chloro-6-(1-piperazinyl)benzo[b][1,4]benzoxazepine, 2-Chloro-11-(1-piperazinyl)dibenzo[b,f][1,4]oxazepine #, 8-chloranyl-6-piperazin-1-yl-benzo[b][1,4]benzoxazepine, Amoxapine, 1.0 mg/mL in methanol, certified reference material, Amoxapine, United States Pharmacopeia (USP) Reference Standard, Dibenzo[b,f][1,4]oxazepine, 2-chloro-11-(1-piperazinyl)-, LOXAPINE SUCCINATE IMPURITY, AMOXAPINE- [USP IMPURITY], Amoxapine, Pharmaceutical Secondary Standard; Certified Reference Material, 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0,3,8]pentadeca-1(11),3(8),4,6,9,12,14-heptaene, 13-chloro-10-(piperazin-1-yl)-2-oxa-9-azatricyclo[9.4.0.0^{3,8}]pentadeca-1(11),3,5,7,9,12,14-heptaene
Pubchem:PUBCHEM:2170
Id:eb0f9f46-85af-5b60-b413-281d0a31bc79
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Amoxapine's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Amoxapine.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Amoxapine.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.